Results
52 out of 56 eligible participants completed the study (two actively refused; two did not complete all questionnaires). Our final sample was racial/ethnically diverse (non-Hispanic white: n=25,48.1%) with equal sex representation (female: n=27,51.9%) (Table 1 ). Leukemia was the most common diagnosis (n=30;57.7%).
Regarding feasibility/acceptability, most participants rated their overall study experience favorably (Table 2 ). A majority felt prepared to answer study questions based on their informed consent. Most participants felt comfortable and had enough privacy to answer sensitive questions. No workflow or technical difficulties were reported.
For descriptive data, 26 participants (50%) reported ACEs (mean total number of ACEs 1.3±1.7; range 0-7). The most common ACEs endorsed were emotional abuse (e.g., parent/caregiver had repeatedly sworn at/insulted/put down the participant; n=12), parental separation/divorce (n=11), and having a member of their household engaged in substance misuse (n=8). The mean resilience score for participants was 75.2±9.0 (range 49-85), indicating overall “High” resilience. Categorical breakdowns were as follows: five scored “Low” (9.6%), eight scored “Moderate” (15.3%), ten scored “High” (19.2%), and 29 scored “Exceptional” (55.8%). Mean age at assessment was different between those with ACEs (15.8±6.0 years) and those without (11.8±7.8 years) [t (46.77)=-2.07,p =0.04]. Those with ACEs were more likely to self-endorse mental health issues [zero ACEs: n=4,15.4%; ≥1 ACE: n=11,42.3%;X2 (1,N=52)=4.59,p =0.03] and substance misuse [zero ACEs: n=6,23.3%; ≥1 ACE: n=14,53.8%;X2 (1,N=52)=5.20,p =0.02]. Participants with ACEs had lower resilience compared to those without ACEs, with five participants with ACEs scoring “Low” (≤62) compared to zero without ACEs and ten participants with ACEs scoring “Exceptional” (≥77) compared to 19 participants without ACEs [X2 (3,N=52)=9.39,p =0.02]. We did not find differences in sex, race/ethnicity, annual household income, insurance type, and chronic health condition endorsement between those with and without ACEs.